BTC $63,600.49 -1.38%
ETH $1,757.98 -3.32%
BNB $584.72 -0.43%
XRP $0.9503 -0.30%
SOL $71.42 +0.80%
TRX $0.3071 +0.82%
DOGE $0.0577 -1.89%
ADA $0.1505 -1.27%
BCH $206.07 +0.12%
LINK $9.00 -1.46%
HYPE $67.52 +0.96%
AAVE $111.63 +3.17%
SUI $0.7123 -0.51%
XLM $0.1370 -0.09%
ZEC $923.41 +6.45%
AAPL $351.45 -1.15%
AMZN $254.55 -2.95%
GOOGL $279.30 -3.47%
MSFT $499.30 -4.63%
META $614.96 -2.55%
NVDA $150.57 -5.79%
TSLA $375.11 -1.56%
SNDK $753.16 -8.54%
INTC $52.60 -6.34%
SPCX $137.77 +0.49%
MU $669.34 -9.23%
AMD $483.02 -5.69%
BTC $63,600.49 -1.38%
ETH $1,757.98 -3.32%
BNB $584.72 -0.43%
XRP $0.9503 -0.30%
SOL $71.42 +0.80%
TRX $0.3071 +0.82%
DOGE $0.0577 -1.89%
ADA $0.1505 -1.27%
BCH $206.07 +0.12%
LINK $9.00 -1.46%
HYPE $67.52 +0.96%
AAVE $111.63 +3.17%
SUI $0.7123 -0.51%
XLM $0.1370 -0.09%
ZEC $923.41 +6.45%
AAPL $351.45 -1.15%
AMZN $254.55 -2.95%
GOOGL $279.30 -3.47%
MSFT $499.30 -4.63%
META $614.96 -2.55%
NVDA $150.57 -5.79%
TSLA $375.11 -1.56%
SNDK $753.16 -8.54%
INTC $52.60 -6.34%
SPCX $137.77 +0.49%
MU $669.34 -9.23%
AMD $483.02 -5.69%

上市公司 Processa 宣布获战略投资,拟将加密货币纳入企业财务管理战略

2025-08-07 20:48:25

ChainCatcher 消息,据 GlobeNewswire 报道,Processa 制药公司(纳斯达克:PCSA)今日宣布获得战略投资,并计划将加密货币纳入企业财务管理战略。该公司已聘请 LifeSci Capital 担任顾问,协助实施相关策略。

Processa 表示,这一决策旨在多元化其资本结构,提升财务灵活性。公司将在严格遵守监管标准的前提下,探索利用区块链资产支持其临床开发项目。

链捕手ChainCatcher提醒,请广大读者理性看待区块链,切实提高风险意识,警惕各类虚拟代币发行与炒作, 站内所有内容仅系市场信息或相关方观点,不构成任何形式投资建议。如发现站内内容含敏感信息,可点击,我们会及时处理。

app_icon
ChainCatcher 与创新者共建Web3世界